Details

Last Funding Type

Series Unknown

Last Funding Money Raised

¥400M

Industries

Health Care,Manufacturing,Pharmaceutical

Founded date

Jan 1, 2005

Number Of Employee

101 - 250

Operating Status

Active

Novast is focused on the research, development and manufacture of value-added generic drugs with release control and other dosage types, and sells them into US pharmaceutical market cooperating with US leading channel.

Cooperating with US sales channels and original development enterprises, it is the first pharmaceutical enterprise in China selling pharmaceutical products into US local market.

Novast Pharmaceutical Company owns cGMP manufacturing facilities covering18, 000 square meters, and its management team has experiences of applying more than 100 generic drug patents in U.S., and many years of working experience in U.S.

Novast also independently researches and develops multiple drug-delivery and dosage type technology.